This W3C-uncheckable vector image was created with other tool. WMF tells W3 the SVG file is image/png!
Extended description
The structure of the Hepatitis B virus as first described by Dane & al.[1] and Jokelainen, Krohn & al.[2] in 1970:
Virion
The hepatitis B virion, is a complex, spherical, double shelled particle with a diameter of 42 nm.[1][2][3]
The 6 nm[2] thick outer viral envelope or membrane contains host-derived lipids and surface proteins,[2] known collectively as HBsAg.[3] The membrane contains globular subunits each measuring ca. 3 to 4 nm in diameter and 3 to 4 nm apart.[2]
Within the membrane sphere is a 2 nm thick icosahedralnucleocapsid inner core composed of protein (HBcAg) with a diameter of 27 nm.[2] When viewed through an electron microscope the inner core may appear pentagonal or hexagonal,[2] depending on the relative position of the sample.
The nucleocapsid contains a viral genome[2] of circular, partially double stranded DNA[3] and endogenous DNA polymerase[4][3] within a diameter of ca. 18 nm.[2]
The virion was initially referred to as the Dane particle.[4] Only after Baruch Blumberg received the Nobel Prize in Medicine in 1976 was it universally accepted that the particle is a virus and the infectious agent of Hepatitis B.
Australia antigen (HBsAg)
The serum of infected patients also contain small spherical and rod-shaped particles with a diameter of ca. 20 nm,[5] consisting of surplus virus-coat material containing the HBsAg antigen.[1][2] This antigen was first discovered by Baruch Blumberg in 1965 in the blood of Australian aboriginal people and initially known as "Australia antigen".[6] It was shown to be associated with "serum hepatitis" by A. M. Prince in 1968.[7]
The outer membrane of the virion is sometimes extended as a tubular tail on one side of the virus particle (not shown);[2][3] these virion "tails" are identical to the small particles.[2][3]
↑ abcD.S. Dane , C.H. Cameron , Moya Briggs (1970). "Virus-Like Particles in Serum of Patients with Australia-Antigen-Associated Hepatitis". The Lancet295: 695–698. DOI:10.1016/S0140-6736(70)90926-8.
↑ abAlmeida J D, Rubenstein D & Scott E J. (1971). "New antigen-antibody system in Australia-antigen-positive hepatitis". The Lancet298 (7736): 1225–7. DOI:10.1016/S0140-6736(71)90543-5.
↑Bayer, M. E., B. S. Blumberg, and B. Werner (1968). "Particles associated with Australia antigen in the sera of patients with leukemia, Down's syndrome and hepatitis.". Nature (London)218: 1057-1059.
↑Baruch S. Blumberg, Harvey J. Alter, and Sam Visnich (Jul 1984). "Landmark article Feb 15, 1965: A 'new' antigen in leukemia sera. By Baruch S. Blumberg, Harvey J. Alter, and Sam Visnich". JAMA252 (2): 252–7. DOI:10.1001/jama.252.2.252. PMID6374187. ISSN0098-7484.
↑Prince, A. M. (1968). "An antigen detected in the blood during the incubation period of serum hepatitis". Proc. Nat. Acad. Sci. U.S.A.60: 814-821.
In case this is not legally possible: TimVickers grants anyone the right to use this work for any purpose, without any conditions, unless such conditions are required by law.
Original upload log
The original description page was here. All following user names refer to en.wikipedia.
2007-11-14 18:14 TimVickers 843×577× (81917 bytes) Simplified drawing of the Hepatitis B virus particle and surface (surplus) antigen
Take
Add a one-line explanation of what this file represents